Catalog Number 08L44-25 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
This report is being filed on an international product, list number 8l44 that has a similar product distributed in the us, list number 6l22.Patient information: (b)(6) female patient diagnosed with malignant lymphoma.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer observed (b)(6) architect anti- hbc ii result on (b)(6) year old female patient diagnosed with malignant lymphoma.The results were provided: (b)(6).Previous history from 2012 (b)(6).There was no reported impact to patient management.
|
|
Manufacturer Narrative
|
A review of tickets was performed for reagent lot number 07400be00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.A retained reagent kit of lot number 07400be00 was tested in a sensitivity setup, including additional replicates of a sensitivity panel.Results of this setup did not implicate that the performance of the lot was negatively impacted.No false non-reactive results were obtained.A manufacturing documentation for the reagent lot was reviewed and did not identify any issues.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation no product deficiency was identified for the architect anti-hbc ii , lot number 07400be00.
|
|
Search Alerts/Recalls
|